Drug search by name

Aminolevulinic Acid (Systemic) and Hepatic impairment

Result of checking the interaction of drug Aminolevulinic Acid (Systemic) and disease Hepatic impairment for safety when used together.

Check result:

Aminolevulinic Acid (Systemic) <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The effect of hepatic impairment on the pharmacokinetics of aminolevulinic acid (ALA) oral solution is unknown. The contribution of the liver to the elimination of ALA is unknown. ALA clearance may be reduced in patients with hepatic impairment. Care should be exercise when administering this agent in patients with liver impairment as it is not known if dose adjustment is needed.

Aminolevulinic Acid (Systemic)

Generic Name: aminolevulinic acid

Brand Name: Gleolan

Synonyms: Aminolevulinic acid

What is Aminolevulinic Acid (Systemic)?